16/05/2025
A study explores improving the detection and follow-up of advanced fatty liver disease
The study includes a series of analyses of 483 liver samples and 169 serum and plasma samples
A study addresses the search for new non-invasive biomarkers to detect and monitor advanced-stage fatty liver disease, also known as MASH (metabolic dysfunction-associated steatohepatitis), one...
See more
»
